DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	NCR3; LY86; ORM1; S100A8; S100A9; FOLR2; AZU1; FCGR2B; CNR2; CARD18; FUT7; NLRP10; PLD4; PROK2; PF4; PTGDR; ACKR1; CCL23; PF4V1; XCL1; CXCL11; CCR2; XCL2; CXCL10;	GO:0006954~inflammatory response	24	381	6.2992125984252	0	0	0	0	0	0	0
up	IGLC7; FCN1; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; IGLV7-43; IGKV4-1; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	36	92	39.1304347826087	0	0	0	0	0	0	0
up	LILRA5; CD300LB; TYROBP; LY86; C1QA; C1QB; S100A8; S100A9; SAA1; RNASE3; DEFA4; CRISP3; NLRP10; CLEC10A; ZNF683; LILRA2; RNASE6; PLD4; SIGLEC10; PLA2G2F; TRIM31; UNC93B1; TLR8; TRIM10; CLEC4A; TRDC; IGHV3-15; IGHV3-48; IGHV1-69-2; IGHV2-26; IGHV4-59; IGHV3-23; IGHV4-39; IGHV3-53; IGHV1-3; IGHV3-30; IGLC3; IGHV3-49; IGLC7; IGHV1-2; IGHV3-21; IGHV6-1; IGLC6; IGHV3-7; IGHV3-72; IGHV1-46; IGHG4; IGHA2; IGLL5; IGHV3-64; FCER1G; IGLC2; IGHV3-73; IGHG3; BPI; IGKC; IGHV2-5; IGHE; IGHD; IGHG2; IGHV3-20;	GO:0045087~innate immune response	61	505	12.0792079207921	0	0	0	0	0	0	0
up	CXCL14; AZU1; SAA2; SAA1; CXCR1; CCR2;	GO:0060326~cell chemotaxis	6	74	8.10810810810811	0.00010774757377052	0.00312467963934515	0.175089807377099	0.181231419082019	0.153755787770536	0.175089807377099	0.0250138471233707
up	GATA1; TAL1; PTPN2; SPI1; TRIM10;	GO:0030218~erythrocyte differentiation	5	46	10.8695652173913	0.00011463772529962	0.00326814667718597	0.186171665886594	0.192820653953972	0.160607453144777	0.186171665886594	0.026162336877842
down	TGM5; PPL; CSTA; CAPN1; KRT19; KRT3; KRT13; KRT5; JUP; DSP; KRT15; TGM1; PCSK6; DSG3; DSG2; DSC3; PRSS8; KRT24; SPINK9; LIPN; KAZN; DSG4; KRT73; CERS3; KRT78; EVPL; PERP; PKP2; TMEM79; SPINK5; PKP3; ST14;	GO:0070268~cornification	32	113	28.3185840707965	0.00012490230342965	0.247973032418506	0.652114926206216	0.652239828509646	0.651740219295927	0.652114926206216	1
up	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.00012615189731191	0.00353645818797722	0.20474452933723	0.212187491278633	0.171936176807636	0.20474452933723	0.0283102380667714
up	ALOX12B; CLDN1; ABCA12; ALOXE3;	GO:0061436~establishment of skin barrier	4	25	16	0.00014809193500386	0.00408345302748373	0.240205118576275	0.249090634676508	0.192223331635022	0.240205118576275	0.0326890694581252
up	IGHD; ORM1; SAA1;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.00016703570294796	0.0044595881326741	0.270597838775695	0.280954052358468	0.208169741161629	0.270597838775695	0.0357001256638541
up	LILRA5; LILRA2; ORAI1; P2RX4;	GO:0051928~positive regulation of calcium ion transport	4	27	14.8148148148148	0.00019331434755476	0.00508054269667361	0.312975928691161	0.325154732587111	0.228298809536056	0.312975928691161	0.0406710232684796
up	TYROBP; NCR1; HLA-G; MNDA; CCR2;	GO:0006968~cellular defense response	5	53	9.43396226415094	0.00021194514582723	0.00540138992850608	0.342927245948459	0.356491735281401	0.241617466243043	0.342715300802631	0.0432394861297463
up	CNR2; CCR2; P2RX4; ALOXE3; PROK2;	GO:0019233~sensory perception of pain	5	53	9.43396226415094	0.00021194514582723	0.00540138992850608	0.342927245948459	0.356491735281401	0.241617466243043	0.342715300802631	0.0432394861297463
down	DLL1; TBX3; IFNG; CCND1; YAP1; SOX9; OSR1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	8	9	88.8888888888889	0.00023188768187409	0.247973032418506	1	1	0.928748415550722	0.999999999999818	1
down	IGLV1-50; TRBV25-1; TRGJ1; TRAV6; TRAV36DV7; TRAV23DV6; TRAV18; TRAJ3; TRAJ42; TRAV30; TRBV16; TRBJ2-7; TRAV14DV4; TRBV6-8; TRAV8-3; TRAV8-1; TRAV16; TRAV19; TRGV5; TRAV2; TRAV13-2; TRAV8-2; TRAV10; TRAV13-1; TRAV12-1; TRAV1-1; TRAV5; TRAV8-6; TRAV39; TRAV38-1; TRAV41; TRAV4; TRAV12-3; TRAV24; TRAV34; TRAV17; TRAV25; TRAV22; TRGV4; TRBJ1-3; TRBJ1-6; TRBJ1-2; TRBJ1-4; TRBV30; TRBV7-7; TRBV7-6; TRDV1; TRBV2; TRBV7-4; TRBV5-6; TRBV11-3; TRBV14; TRBV29-1; TRAV38-2DV8; TNFRSF21; TRGV3; ANXA1; CD3G; TRBD1; CTLA4; IL2; ARG2; SLAMF1; CLEC6A; TRAT1; SKAP1; CLEC4C; CD84; TNFSF18; IFNG; IFNA5;	GO:0002250~adaptive immune response	71	347	20.4610951008646	0.00023743109193652	0.247973032418506	1	1	0.936313699435966	0.999999999999818	1
up	XCL1; CD1C; HLA-G; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	4	29	13.7931034482759	0.00024772101988168	0.006127452285897	0.400317168128804	0.416666755440996	0.266300096372812	0.400069447108923	0.0490517980804257
up	CXCL11; CXCL10; CD19; XCL1;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	4	29	13.7931034482759	0.00024772101988168	0.006127452285897	0.400317168128804	0.416666755440996	0.266300096372812	0.400069447108923	0.0490517980804257
up	PSENEN; PRELID1; PSME1;	GO:0010950~positive regulation of endopeptidase activity	3	11	27.2727272727273	0.00027254975237434	0.00654898119276629	0.439895300332185	0.45842868349364	0.280453695193196	0.439622750579811	0.0524262430960817
up	LTF; CARD16; LILRA2;	GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway	3	11	27.2727272727273	0.00027254975237434	0.00654898119276629	0.439895300332185	0.45842868349364	0.280453695193196	0.439622750579811	0.0524262430960817
up	CLDN5; PF4; CXCL10; HLA-G; CCR2; HHEX;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.00027704560219377	0.00656324933647778	0.446597510736358	0.465990702889922	0.282900474453724	0.446597510736358	0.0525404631783709
up	CEACAM4; ICAM3; CEBPE; PLD4; ELANE;	GO:0006909~phagocytosis	5	57	8.7719298245614	0.00029029875467401	0.00678170146335678	0.467671293779834	0.488282505361688	0.290283724631265	0.467671293779834	0.0542892274474247
up	LTF; VTCN1; BTNL3; BTNL8;	GO:0001817~regulation of cytokine production	4	31	12.9032258064516	0.00031233582931045	0.00719655979315312	0.502860685189825	0.525348864900178	0.302341082772516	0.502860685189825	0.057610272814353
up	SAA1; XCL2; CCL23; XCL1;	GO:0048247~lymphocyte chemotaxis	4	33	12.1212121212121	0.00038820499027925	0.00882379450877972	0.624621829359314	0.6529607936497	0.337738341542948	0.624621829359314	0.0706366963548654
up	CCR2; TBX21; PRELID1;	GO:0045580~regulation of T cell differentiation	3	13	23.0769230769231	0.00041351935438804	0.00927386072107595	0.664939121855981	0.695539554080696	0.34761085985833	0.664939121855981	0.0742395896844778
up	LILRA5; ORM1; LILRA2; TLR8;	GO:0050718~positive regulation of interleukin-1 beta secretion	4	35	11.4285714285714	0.00047639307150948	0.010439628475043	0.765563665915741	0.801293146278953	0.372062988848907	0.765563665915741	0.0835718540266865
up	IDO1; MMP8; FCGR2B;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.0004986554217703	0.010439628475043	0.800840607363102	0.838738419417644	0.380798858998472	0.800341951941331	0.0835718540266865
up	ADRA2A; KCNQ1; MOGAT2;	GO:0050892~intestinal absorption	3	14	21.4285714285714	0.0004986554217703	0.010439628475043	0.800840607363102	0.838738419417644	0.380798858998472	0.800341951941331	0.0835718540266865
up	HP; ORM1; SAA1; SAA2;	GO:0006953~acute-phase response	4	37	10.8108108108108	0.00057797923243851	0.0113156512314376	0.924188792669192	0.972161068961589	0.410919736751581	0.923610813436754	0.0905846367225927
up	LILRA5; NLRP10; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	4	37	10.8108108108108	0.00057797923243851	0.0113156512314376	0.924188792669192	0.972161068961589	0.410919736751581	0.923610813436754	0.0905846367225927
up	CXCL11; PF4; CXCL10; ADRA2A; ADGRE3; PTGDR;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	6	103	5.8252427184466	0.00057856480731488	0.0113156512314376	0.924188792669192	0.973146005903637	0.410919736751581	0.923967997281872	0.0905846367225927
up	RBP1; USF1; HNF4A; ABCA12;	GO:0055088~lipid homeostasis	4	38	10.5263157894737	0.00063413694252434	0.012259980888804	1	1	0.426583853766362	0.983724267346631	0.0981442333564342
up	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.00070078902137094	0.013244125100516	1	1	0.44493797161084	0.983724267346631	0.106022555520774
up	FOLR1; MAG; GAP43;	GO:0031103~axon regeneration	3	16	18.75	0.00070078902137094	0.013244125100516	1	1	0.44493797161084	0.983724267346631	0.106022555520774
up	CXCL10; RNASE2; AZU1; LILRB1; RNASE6; UNC93B1; EXOSC5; TLR8;	GO:0051607~defense response to virus	8	198	4.04040404040404	0.00076704447404696	0.0143352089482999	1	1	0.461981021765214	0.983724267346631	0.114756956392975
up	TYROBP; FCER1G; ABCA12;	GO:2000010~positive regulation of protein localization to cell surface	3	17	17.6470588235294	0.00081875964610278	0.0144970616858809	1	1	0.474011572324899	0.983724267346631	0.116052628302304
up	CA4; HBA1; RHAG; SLC26A9;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.0008977338409013	0.0150998832039599	1	1	0.491958144813915	0.983724267346631	0.120878366309502
up	KRT9; KRT20; KRT17;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00094862093632541	0.0154910719893141	1	1	0.503717717188797	0.983724267346631	0.124009931014573
up	DUOXA2; TESC; ISCA2;	GO:0051604~protein maturation	3	18	16.6666666666667	0.00094862093632541	0.0154910719893141	1	1	0.503717717188797	0.983724267346631	0.124009931014573
up	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.00094862093632541	0.0154910719893141	1	1	0.503717717188797	0.983724267346631	0.124009931014573
down	OVOL1; SNAI2; FBLN1; KDF1; FERMT1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	6	6	100	0.0009875018370753	0.674214760285449	1	1	0.999999999999818	0.999999999999818	1
up	AKR1B15; AKR1B10; CYP1A1; ALDH1A3;	GO:0042572~retinol metabolic process	4	44	9.09090909090909	0.00105484141282108	0.0169884959148851	1	1	0.527773095138493	0.983724267346631	0.135997186501974
up	LTF; RNASE3; DEFA4;	GO:0002227~innate immune response in mucosa	3	19	15.7894736842105	0.00109081900048014	0.0169884959148851	1	1	0.536028374307004	0.983724267346631	0.135997186501974
up	GATA1; TAL1; CLEC1B;	GO:0030220~platelet formation	3	19	15.7894736842105	0.00109081900048014	0.0169884959148851	1	1	0.536028374307004	0.983724267346631	0.135997186501974
up	FCN1; TRIM31; TRIM10;	GO:0046597~negative regulation of viral entry into host cell	3	19	15.7894736842105	0.00109081900048014	0.0169884959148851	1	1	0.536028374307004	0.983724267346631	0.135997186501974
up	ID2; OLIG2; OLIG1;	GO:0048663~neuron fate commitment	3	19	15.7894736842105	0.00109081900048014	0.0169884959148851	1	1	0.536028374307004	0.983724267346631	0.135997186501974
up	LILRA5; S100A8; S100A9; CCR2; NLRP10;	GO:0050729~positive regulation of inflammatory response	5	78	6.41025641025641	0.00110981704492186	0.017125800638152	1	1	0.539561167183076	0.983724267346631	0.137096345376973
down	ERBB2; ERBB3; BDKRB2; TRAT1; IL31RA; CNKSR1; NRTN; BLNK; FRK; BCAR1; KDR; SLA; EGFR; DDR1; PTK6; FGFR3; CLNK; EPHA3; NTRK1; EPHB3; TNK1; TYRO3; EPHA2; BDNF; EPHA1; FGFR2; FLT3; NTRK2; ROR1; EFS;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	30	120	25	0.00113017118421899	0.674214760285449	1	1	0.999999999999818	0.999999999999818	1
up	S100A8; S100A9; UNC93B1; TLR8;	GO:0002224~toll-like receptor signaling pathway	4	45	8.88888888888889	0.00114020542164006	0.0174347774472598	1	1	0.544117829321616	0.983724267346631	0.139569782516055
down	TGM5; SCEL; GJB5; KRT5; DSP; KRT15; FGF7; CRABP2; DCT; ALDH3A2; EMP1; ELF3; LAMB3; LAMC2; CST6; ZNF750; GRHL2; CERS3; GRHL3; EVPL; GRHL1; POU2F3; COL17A1;	GO:0008544~epidermis development	23	82	28.0487804878049	0.00116199403342954	0.674214760285449	1	1	0.999999999999818	0.999999999999818	1
up	CXCL14; C1QB; KCNQ1; CYTL1;	GO:0048839~inner ear development	4	46	8.69565217391304	0.00123029335675273	0.0176817990823489	1	1	0.557322890608988	0.983724267346631	0.141547252890451
up	TNFSF12; TNFSF13; KRT8; PSMB8; PSME1; COMMD7;	GO:0033209~tumor necrosis factor-mediated signaling pathway	6	120	5	0.00123242558677461	0.0176817990823489	1	1	0.557379831092465	0.983724267346631	0.141547252890451
up	CCL23; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	3	20	15	0.00124578434270262	0.0176817990823489	1	1	0.559357169873475	0.983724267346631	0.141547252890451
up	KRT14; SPRR1B; KRT9; SPRR3; KRTDAP;	GO:0008544~epidermis development	5	82	6.09756097560976	0.00137008089805757	0.0188891481191216	1	1	0.576804058082236	0.983724267346631	0.151212385869238
up	TYROBP; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	3	21	14.2857142857143	0.00141393217182617	0.0191773688152753	1	1	0.582540054792382	0.983724267346631	0.153519665098956
up	SAA1; AZU1; FUT7; EPB41L4B;	GO:0045785~positive regulation of cell adhesion	4	48	8.33333333333333	0.00142519090482129	0.0191773688152753	1	1	0.583999137518946	0.983724267346631	0.153519665098956
up	POMC; ORM1; BPI; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	4	49	8.16326530612245	0.0015302745986121	0.0204279513878219	1	1	0.597634914754261	0.983724267346631	0.163530893415273
up	SPI1; CEBPE; NKX2-3;	GO:0030225~macrophage differentiation	3	22	13.6363636363636	0.00159566270591527	0.0211331076484211	1	1	0.606351828247802	0.983724267346631	0.16917584679821
down	PRSS37; FOXE1; LAMA5; PLXNB1; CDK1; PTPRF; CEACAM1; JUP; HOXA5; EFNA1; CD24; EPHA2; EPHA3; L1CAM; BDKRB1; EPHB3; EMP2; BCAR1; SHROOM2; PTK6; DOCK1; HES1; SKAP1; WWC1; ASAP3; ELMO3; RHBDF1; FAM83D; LAMB3; GPC4; TYRO3; KDR; SDC1; GPC1; LAMB2; ITGB4; ITGB6; LAMB4; PIK3C2G; NCKAP1L; RHOV; EFS; SDC4; NCKAP1; LAMC3; RHOD; ITGB5;	GO:0016477~cell migration	47	225	20.8888888888889	0.00169415215392987	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CXCL14; CXCL10; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.00200139959841605	0.0244339038020328	1	1	0.65430864892056	0.983724267346631	0.195599550954057
up	MMP8; FCER1G; SCIMP; TLR8;	GO:0032755~positive regulation of interleukin-6 production	4	53	7.54716981132075	0.00200468414071375	0.0244339038020328	1	1	0.65430864892056	0.983724267346631	0.195599550954057
up	GZMA; FCGR2B; CD79B; FER1L6; RNF5;	GO:0009617~response to bacterium	5	92	5.43478260869565	0.00221499771026634	0.0267454112327353	1	1	0.673359303920968	0.983724267346631	0.214103749838344
up	RNASE2; RNASE3; RNASE6;	GO:0006401~RNA catabolic process	3	25	12	0.00222613410974015	0.0267454112327353	1	1	0.674344606190159	0.983724267346631	0.214103749838344
up	ELANE; TNNI3; KEL; CCR2; CCL23;	GO:0006874~cellular calcium ion homeostasis	5	94	5.31914893617021	0.00242126472036963	0.0273672160756931	1	1	0.687900275970835	0.983724267346631	0.219081454140081
up	CLDN1; CYP1A1; S100A8; ELANE; IDO1; CNR2;	GO:0032496~response to lipopolysaccharide	6	138	4.34782608695652	0.00242432532418446	0.0273672160756931	1	1	0.688508392068387	0.983724267346631	0.219081454140081
up	IDO1; HLA-G; SCIMP;	GO:0032735~positive regulation of interleukin-12 production	3	26	11.5384615384615	0.00246590820681414	0.0276510506924092	1	1	0.691103270520961	0.983724267346631	0.221353621699743
up	C1QA; AZU1; TLR8;	GO:0001774~microglial cell activation	3	27	11.1111111111111	0.00272105155034319	0.0301105836031398	1	1	0.70913059586853	0.983724267346631	0.241042801815759
up	S100A8; S100A9; BATF;	GO:0001816~cytokine production	3	27	11.1111111111111	0.00272105155034319	0.0301105836031398	1	1	0.70913059586853	0.983724267346631	0.241042801815759
up	CTSV; CTSE; HLA-DMB; FCGR2B; FCER1G;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	5	98	5.10204081632653	0.00287511562760889	0.0311126303905367	1	1	0.719638235781063	0.983724267346631	0.249064438605271
up	CYP1A1; HRH2; CLDN18;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.00299188053635024	0.0311126303905367	1	1	0.727712209667877	0.983724267346631	0.249064438605271
up	MUC3A; MUC16; MUCL1; MUC13;	GO:0016266~O-glycan processing	4	60	6.66666666666667	0.0030636805858153	0.0316141763517873	1	1	0.732624442520023	0.983724267346631	0.253079440284834
down	SNAI2; GREM1; PTH; RARB; BMP4; RARG; SOX9; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	9	20	45	0.00335522862942761	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	SPDEF; POMC; PF4; CXCL10; GATA1; EPCAM; TAL1; SPI1; USF1; HNF4A; HHEX; CAMK1; CEBPE; BATF; MLIP; NFE4; LILRB1; CYTL1; ASCL2; NKX2-3; TBX21;	GO:0045944~positive regulation of transcription by RNA polymerase II	21	1138	1.84534270650264	0.00338808892176223	0.0347485705268541	1	1	0.754700925665707	0.983724267346631	0.278171054712205
up	CYP1A1; GAP43; CCR2; HHEX;	GO:0009611~response to wounding	4	62	6.45161290322581	0.0034248280984801	0.0349124900705669	1	1	0.756836263539948	0.983724267346631	0.279483271924919
up	CYP1A1; XCL1; LILRB1; TLR8; TBX21;	GO:0009615~response to virus	5	104	4.80769230769231	0.00366678769396134	0.036193401664184	1	1	0.769448851854758	0.983724267346631	0.289737291689967
up	GATA1; TAL1; ID2;	GO:0045648~positive regulation of erythrocyte differentiation	3	31	9.67741935483871	0.00390145201587933	0.0372854675608467	1	1	0.778933393458066	0.983724267346631	0.298479554110666
up	ALOX12B; P2RX1; ALOXE3;	GO:0046513~ceramide biosynthetic process	3	31	9.67741935483871	0.00390145201587933	0.0372854675608467	1	1	0.778933393458066	0.983724267346631	0.298479554110666
up	S100A8; S100A9; CAPN6;	GO:0051493~regulation of cytoskeleton organization	3	31	9.67741935483871	0.00390145201587933	0.0372854675608467	1	1	0.778933393458066	0.983724267346631	0.298479554110666
up	LTF; S100A8; S100A9; CARD16; RHEBL1; CRNN;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	6	154	3.8961038961039	0.00407321762492463	0.0387070737012612	1	1	0.786060888561604	0.983724267346631	0.309859869141433
down	DRGX; MATN2; CHL1; FLRT2; NRP2; NFASC; NTRK1; NGFR; GLI3; BMP7; BDNF; PAX6; L1CAM; GPC1; WNT5A; EPHB3; LAMB2; VLDLR; PTK2; SEMA3F; CRMP1; GRB7; APBB2; NRTN; BOC; OR10A4; FLRT3; MYOT; ROBO1; EPHA3; EFNA5; IGSF9; LAMA1; EFNB2; CYFIP1; UNC5B; EFNB1; EPHA2; EFNA1; EPHA1; EFNB3; UNC5C;	GO:0007411~axon guidance	42	206	20.3883495145631	0.00416022942182992	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	DSP; DSG2; GRHL1; PKP2; PERP;	GO:0002934~desmosome organization	5	6	83.3333333333333	0.00450241730207745	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	JUP; DSP; DSG2; PKP2; CTNNA3;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	5	6	83.3333333333333	0.00450241730207745	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	EGFR; ERBB2; DCN; GLI3; SDC1; FGFR2; ERBB3; CDH3; LOX; SDC4; OPRM1; WNT5A; FUT10; GRHL3; DCBLD2; WNT5B; VANGL2; DSP; DST; EVPL; PPL;	GO:0042060~wound healing	21	82	25.609756097561	0.00459227969801401	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	AKR7A3; IDO1; GPX2; GLRX;	GO:0022900~electron transport chain	4	68	5.88235294117647	0.00467954116257019	0.0416454403991696	1	1	0.808439261168624	0.983724267346631	0.333382234265971
up	GATA1; TAL1; PSMB8; PSME1;	GO:1902036~regulation of hematopoietic stem cell differentiation	4	68	5.88235294117647	0.00467954116257019	0.0416454403991696	1	1	0.808439261168624	0.983724267346631	0.333382234265971
down	DLL1; TBX3; BIRC5; VEGFD; GREM1; LRP5; FGF18; CLDN7; NTN1; EGFR; F2; HRAS; GHRH; IFNG; WNT1; CAPN1; PKHD1; BMP4; RARG; OSM; EDN3; FOSL1; AREG; VEGFA; EDN2; PTN; KITLG; EPHA1; FGF7; FGFR2; FGFR3; EDNRB; ADRA1D; AVPR2; ALDH3A1; DRD3; KDR; FLT3; CEACAM6; LIFR; SOX9; EFNB2; AKR1C2; CRIP2; EMP2; CAV3; RAB25; IL2; CX3CL1; PTK2; FOXM1; CDC20; TBX2; SLAMF1; LAMC2; KLF5; HES1; CTF1; NTRK2; IL34; NCCRP1; SAPCD2; KLB; MYOCD; SFRP1; IL31RA; PROX1; TSLP; LGMN; S100A13; OSMR; WWTR1; GAREM1; IL21; ARNT2; ESM1; C8orf17; TRPC5; MAB21L2; HILPDA; ERBB2; ERBB3; PRL; BTC; CSF3;	GO:0008284~positive regulation of cell population proliferation	85	490	17.3469387755102	0.00471817404551123	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	NEURL1; SPDEF; GZMA; MNDA; ALDH1A3; LILRB1; PNMA5; PSENEN; SCIMP;	GO:0043065~positive regulation of apoptotic process	9	332	2.71084337349398	0.00513780064050584	0.045483056196478	1	1	0.817617284136105	0.983724267346631	0.364103314809198
up	SMIM22; CXCL11; PF4; CXCL10; TAL1; NKX2-3;	GO:0042127~regulation of cell population proliferation	6	163	3.68098159509202	0.00530334538115451	0.0465164015765345	1	1	0.821621473260839	0.983724267346631	0.372375504712094
up	POMC; ADRA2A; PTPN2; USF1; HNF4A;	GO:0042593~glucose homeostasis	5	114	4.3859649122807	0.00531560747150339	0.0465164015765345	1	1	0.821621473260839	0.983724267346631	0.372375504712094
down	SNAI2; FGFR2; SFN; EFNB2; CD109; KDF1; INTU;	GO:0010839~negative regulation of keratinocyte proliferation	7	14	50	0.00610556906796522	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	TYROBP; C1QA; FCGR2B;	GO:1901216~positive regulation of neuron death	3	38	7.89473684210526	0.00662353468000187	0.0557039266588158	1	1	0.848419879736372	0.983724267346631	0.445923955873788
up	GJB1; PSMB8; PSME1; SLC44A4; SPNS3; ABCA12; RNF5; ABCC13;	GO:0055085~transmembrane transport	8	285	2.80701754385965	0.00667576075842102	0.0558638288341501	1	1	0.849710672859205	0.983724267346631	0.447204013041295
up	CARD18; CAMK1; CARD16; DTNBP1;	GO:0032091~negative regulation of protein binding	4	77	5.19480519480519	0.00708829227496555	0.059022314883624	1	1	0.857992197053222	0.983724267346631	0.472488488988211
down	BMP4; BMP7; WNT5A; SULF1;	GO:0060686~negative regulation of prostatic bud formation	4	4	100	0.00752916852045615	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	ANXA8; PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	4	4	100	0.00752916852045615	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	LRP4; DKK1; CALCA; MDK; SOX9; SFRP1; KREMEN2; KREMEN1;	GO:0030279~negative regulation of ossification	8	19	42.1052631578947	0.00761534412640352	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CLDN1; TCL1A; XCL2; CCL23; XCL1;	GO:0071356~cellular response to tumor necrosis factor	5	125	4	0.00766912678921905	0.0614260536165069	1	1	0.870696470727199	0.983724267346631	0.491731022664866
down	PCDH17; PCDH7; MPZL2; CDH1; CEACAM1; DSG3; CEACAM6; CDH13; PCDH1; DSG2; DSC3; DSG4; NECTIN2; CADM1; PCDH18; CELSR2; FAT2; CD84; PCDHGC3; IGSF9B; PCDHB14; PCDHB13; PCDHGB7; PCDHGB5; PCDHGA9; ROBO1; NECTIN4; MYOT; IGSF9; L1CAM; CDH26; CDH3; HMCN1; CDH24;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	34	165	20.6060606060606	0.00801945464604503	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	LAMA5; BMP7; FGF7; FGFR2; LAMA1; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	6	11	54.5454545454545	0.00807628912108882	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	DSP; ITGB5; PLEKHA7; BVES; KIFC3; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	6	11	54.5454545454545	0.00807628912108882	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	BMP4; HOXA5; LAMA1; SOX9; FOXA1; DLG5; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	7	15	46.6666666666667	0.0081032460713083	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	CCL24; PLXNB1; ATP10A; F2; ANXA1; CCL2; VEGFA; PTN; KDR; P2RY1; CCL7; FGD1; CDC42EP1; PTK2; FGD5; CYFIP1; MYH14; PDPN; BVES; SHROOM3; FBLIM1; DLC1; S100A13; MYO10; PALMD; PARVA; BAIAP2; RHOV; RND3; WIPF3; RHOD; C15orf62; PLXNA2;	GO:0008360~regulation of cell shape	33	159	20.7547169811321	0.00814375944570167	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TRPA1; TSPAN12; EGFR; F2; HRAS; PRL; IFNG; IL2RA; ERBB2; CD3G; CCL2; CD59; EDN3; NPR1; EDN2; EPHA1; EDNRB; LAMA1; BDKRB2; LIFR; GLP1R; SCTR; P2RY1; CCR5; ADGRF1; GPR157; ADGRF5; ADGRV1; MAGI1; GPHA2; CD80; TRBV7-1; TRBV6-8; TRBV17; TRBV2; TRBV25-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV7-7; TRBV14; CTF1; TRBV5-7; TRBV30; TRBV6-7; TRBV7-4; TRBV5-6; TRBV16; TRBV23-1; ANXA1;	GO:0007166~cell surface receptor signaling pathway	50	268	18.6567164179104	0.00846223045402938	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CXCR1; FCER1G; LILRB1;	GO:0031623~receptor internalization	3	42	7.14285714285714	0.00857833937703756	0.0661870038173265	1	1	0.882637755900367	0.983724267346631	0.529843627549455
up	S100A8; S100A9; KRT17; SLC44A4;	GO:0030307~positive regulation of cell growth	4	82	4.8780487804878	0.0087250696814265	0.0670117223934218	1	1	0.883673605181803	0.983724267346631	0.536445707366692
up	CLDN5; LIM2; DSG1;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.00911419557716742	0.0696821680036163	1	1	0.888055128579144	0.983724267346631	0.55782329673732
up	P2RX4; NMUR1; CCR2; CXCR1;	GO:0019722~calcium-mediated signaling	4	85	4.70588235294118	0.00981628896898723	0.0727356742107336	1	1	0.894084712421231	0.983724267346631	0.582267382618425
up	AZU1; FCGR2B; FCER1G;	GO:0050766~positive regulation of phagocytosis	3	45	6.66666666666667	0.0102434954578261	0.0755682428072961	1	1	0.898513310336361	0.983724267346631	0.604942807307954
down	SULT2B1; BMP4; SFN; KDF1; IL20;	GO:0045606~positive regulation of epidermal cell differentiation	5	8	62.5	0.0103582671438078	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PCDH17; PTPRF; EFNA5; SPARCL1; LRRC4B; FLRT3; IGSF9B; NTNG1; GPC4;	GO:0099560~synaptic membrane adhesion	9	25	36	0.0105183562848319	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CXCL10; SAA1; SAA2;	GO:0050918~positive chemotaxis	3	46	6.52173913043478	0.0108371882863012	0.0772379266845704	1	1	0.903414292029105	0.983724267346631	0.618309047073657
down	KRT5; ITGB4; LAMB3; LAMC2; COL17A1; DST;	GO:0031581~hemidesmosome assembly	6	12	50	0.0109853067516351	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	CCL21; NRG2; FGF18; EGFR; F10; ERBB2; CSF3; TXN; OSM; AREG; KITLG; FGF7; FGFR2; ERBB3; FGFR3; IGFBP5; CD80; BTC; AKR1C2; CX3CL1; PTK2; SEMA5A; IL18; FAM110C; TNFAIP8L3; TRAT1; KLB; PIK3R5; C1QTNF1; FGF23; FGF22; IL26; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	33	165	20	0.0127177066279104	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	ELANE; SAA1; PTPN2; CNR2;	GO:0050728~negative regulation of inflammatory response	4	93	4.3010752688172	0.0131472395970431	0.0824439938224367	1	1	0.922946943766939	0.983724267346631	0.659984925093549
up	UBE2L6; LTF; CTSG; SAA1; PSENEN; NAT8B;	GO:0044267~cellular protein metabolic process	6	200	3	0.0133018311543255	0.0824439938224367	1	1	0.923734777265673	0.983724267346631	0.659984925093549
down	CCL24; CCL21; SIGLEC6; GREM1; FGF18; GHRH; THY1; WNT1; EDN3; AREG; GJA1; TRH; EFNA1; FGFR2; FGFR3; GJB2; SSTR3; CCR5; EFNB2; IL2; CX3CL1; CCL20; CCL7; CRB1; EFNB1; PCDH1; GRAP; SEMA5A; IL18; EFNB3; CTF1; TFAP2C; BARX1; IL26; TNFSF18; CCL26; GPR101; DRD2; PTH; ADRA1D; FGFBP1; FJX1; DRD3;	GO:0007267~cell-cell signaling	43	230	18.695652173913	0.0133385561021898	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	HP; KCNA5; HBA1;	GO:0042542~response to hydrogen peroxide	3	50	6	0.0134080769205713	0.0824439938224367	1	1	0.924546851795137	0.983724267346631	0.659984925093549
up	PRKCG; P2RX1; DTNBP1;	GO:2000300~regulation of synaptic vesicle exocytosis	3	50	6	0.0134080769205713	0.0824439938224367	1	1	0.924546851795137	0.983724267346631	0.659984925093549
up	RNASE2; RNASE3; DEFA4; RNASE6;	GO:0050830~defense response to Gram-positive bacterium	4	95	4.21052631578947	0.0140791493744896	0.0824439938224367	1	1	0.927140251098911	0.983724267346631	0.659984925093549
up	LTF; TCL1A; CAMK1;	GO:0071902~positive regulation of protein serine/threonine kinase activity	3	51	5.88235294117647	0.0141002796668496	0.0824439938224367	1	1	0.927140251098911	0.983724267346631	0.659984925093549
up	CLDN1; CCL23; XCL1; XCL2;	GO:0071346~cellular response to interferon-gamma	4	96	4.16666666666667	0.0145603861052083	0.0824439938224367	1	1	0.929013261707191	0.983724267346631	0.659984925093549
down	AREG; MDK; FGF7; CDH3; TGM1; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	6	13	46.1538461538462	0.0145631500947403	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	E2F8; WNT1; ITGA2; CPS1; PROX1; ANXA1;	GO:0070365~hepatocyte differentiation	6	13	46.1538461538462	0.0145631500947403	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	MELTF; TACSTD2; FBLN1; EFNA5; KANK1; POSTN;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	6	13	46.1538461538462	0.0145631500947403	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	MATN2; CD9; P2RY1; CSPG4; NDN;	GO:0008347~glial cell migration	5	9	55.5555555555556	0.0146503199432509	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	SAA1; PROK2; PTGDR; CCR2; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	5	150	3.33333333333333	0.0155193047248315	0.0824439938224367	1	1	0.931158283489892	0.983724267346631	0.659984925093549
up	KRT10; SPRR1B; SPRR3;	GO:0030216~keratinocyte differentiation	3	53	5.66037735849057	0.0155445812864544	0.0824439938224367	1	1	0.931243925803163	0.983724267346631	0.659984925093549
up	MMP3; TAL1; TCL1A;	GO:0031334~positive regulation of protein-containing complex assembly	3	54	5.55555555555556	0.0162967977946074	0.0824439938224367	1	1	0.931788512894276	0.983724267346631	0.659984925093549
down	ALOX15B; MT1E; MT1G; IGFBP5; MT1H; MT1X; PTK6;	GO:0045926~negative regulation of growth	7	18	38.8888888888889	0.0169483617581098	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	ITGA2; EDN2; CTTN; NPNT; MYOCD; NMU; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	7	18	38.8888888888889	0.0169483617581098	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	GREM1; VEGFA; SOX9; SOX8; WNT2B; SMO; LGR4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	7	18	38.8888888888889	0.0169483617581098	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	TAL1; GAP43; GATA1;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.0170691242404224	0.0824439938224367	1	1	0.932681030626933	0.983724267346631	0.659984925093549
up	PSMB8; PSME1; MIIP;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	3	56	5.35714285714286	0.017861601275296	0.0824439938224367	1	1	0.933333255123875	0.983724267346631	0.659984925093549
down	FOXP2; LRP5; VEGFA; FGFR2; WNT5A; SOX9; PRRX1; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	8	23	34.7826086956522	0.0180747447974172	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TLCD2; CAV3; CRB1; BAIAP2L2; TLCD1; A4GALT; BAIAP2L1; BAIAP2;	GO:0007009~plasma membrane organization	8	23	34.7826086956522	0.0180747447974172	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	RHOD; GREM1; EPHA3; EFNA5; PTK2; GPM6B; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	8	23	34.7826086956522	0.0180747447974172	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TBX3; RARB; BMP4; RARG; MSX1; PITX1; OSR1; ALX4; TP63;	GO:0035116~embryonic hindlimb morphogenesis	9	28	32.1428571428571	0.0183760567796254	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PHGDH; SHMT1; BAAT; GLYAT;	GO:0006544~glycine metabolic process	4	6	66.6666666666667	0.0187998990758081	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	GHRH; DRD2; SOX2; HES1;	GO:0021984~adenohypophysis development	4	6	66.6666666666667	0.0187998990758081	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PLK1; ESPL1; PTTG3P; PTTG2;	GO:0045143~homologous chromosome segregation	4	6	66.6666666666667	0.0187998990758081	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	WNT5A; GRHL3; DLG3; TP63; INTU; VANGL2;	GO:0001736~establishment of planar polarity	6	14	42.8571428571429	0.0188762736605724	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	ID2; OLIG2; ISL2;	GO:0045665~negative regulation of neuron differentiation	3	59	5.08474576271187	0.0203602390642459	0.0894149402247039	1	1	0.936072598011031	0.983724267346631	0.715789105917689
down	NEURL1B; DLL1; SNAI2; IL2RA; KRT19; MDK; SOX9; FOXA1; JAG1; CNTN1; TBX2; HES1; NRARP; DNER; PERP; CHAC1; TP63; HEYL; DLL4; NOTCH3; JAG2; DLK2; SORBS2;	GO:0007219~Notch signaling pathway	23	109	21.1009174311927	0.0207033906798357	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	ELANE; ADRA2A; PIK3R6;	GO:0043406~positive regulation of MAP kinase activity	3	60	5	0.0212335883049223	0.0925256360851795	1	1	0.936535084472499	0.983724267346631	0.740691009370916
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PLEKHA7; KIFC3; CAMSAP3;	GO:0045218~zonula adherens maintenance	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PTN; SOX9; SOX8;	GO:0060221~retinal rod cell differentiation	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	HOXA5; WNT5A; WNT2B;	GO:0060638~mesenchymal-epithelial cell signaling	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SPINT2; GRHL2; ST14;	GO:0060672~epithelial cell morphogenesis involved in placental branching	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SOX9; WNT4; SOX8;	GO:0072034~renal vesicle induction	3	3	100	0.0215146784314832	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	NEURL1; FCER2; KCNA5; NR0B2;	GO:0007219~Notch signaling pathway	4	109	3.6697247706422	0.0217738825877583	0.0943909033830139	1	1	0.937019081932175	0.983724267346631	0.755622943654595
up	LILRA5; ALOX12B; ADRA2A; MMP8;	GO:0043410~positive regulation of MAPK cascade	4	109	3.6697247706422	0.0217738825877583	0.0943909033830139	1	1	0.937019081932175	0.983724267346631	0.755622943654595
up	POMC; P2RX1; P2RX4;	GO:0008217~regulation of blood pressure	3	61	4.91803278688525	0.02212719032357	0.0944361090587849	1	1	0.93752612688993	0.983724267346631	0.755984826469271
up	CLDN1; KRT14; C1QA; CYP1A1; RETN;	GO:0007568~aging	5	166	3.01204819277108	0.0226523855001531	0.0944361090587849	1	1	0.938057905748064	0.983724267346631	0.755984826469271
up	TNFSF13; PSMB8; PSME1; EXOSC5;	GO:0043488~regulation of mRNA stability	4	112	3.57142857142857	0.0236983168114765	0.0944361090587849	1	1	0.939203275596352	0.983724267346631	0.755984826469271
up	AKR1B10; RBP1; STRA6;	GO:0001523~retinoid metabolic process	3	63	4.76190476190476	0.0239751521111076	0.0944361090587849	1	1	0.939203275596352	0.983724267346631	0.755984826469271
down	UNC13B; GIPC1; PPFIA3; GJA1; BDNF; SLC1A3; SLC1A1; STXBP1; NTRK2;	GO:0014047~glutamate secretion	9	30	30	0.0255556112354856	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	IFNG; APOD; NPR1; NPR3; IGFBP5; PPARG; PPARGC1A; NDRG4; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	9	30	30	0.0255556112354856	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	PRKCG; HNF4A; ID2;	GO:0042752~regulation of circadian rhythm	3	65	4.61538461538462	0.0259040641731052	0.0944361090587849	1	1	0.941159949087178	0.983724267346631	0.755984826469271
down	CLDN4; ALOX12; SFN; KDF1; GRHL3; TMEM79; TP63; GRHL1;	GO:0061436~establishment of skin barrier	8	25	32	0.0260328735972308	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	VEGFA; ITGA2; KITLG; BDKRB1; TNFSF18;	GO:0002687~positive regulation of leukocyte migration	5	11	45.4545454545455	0.0264528736450242	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	LAMA5; FGFR2; KDF1; JAG2; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	5	11	45.4545454545455	0.0264528736450242	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	FUT1; FUT3; FUT2; FUT6; FUT10;	GO:0036065~fucosylation	5	11	45.4545454545455	0.0264528736450242	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	ITGB4; ITGA2; FGFR2; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.0264528736450242	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	JUP; DSP; DSG2; PKP2; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.0264528736450242	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	PSMB8; PSME1; BTNL3; VTCN1; BTNL8;	GO:0050852~T cell receptor signaling pathway	5	174	2.8735632183908	0.0269008517783017	0.0944361090587849	1	1	0.941886713526628	0.983724267346631	0.755984826469271
down	BMP4; EPHA2; SEMA5A; NRARP;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	4	7	57.1428571428571	0.0269698886607714	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	IGSF3; FGFR2; PAX6; SOX9;	GO:0032808~lacrimal gland development	4	7	57.1428571428571	0.0269698886607714	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SPRY1; BMP4; FGFR2; YAP1;	GO:0060449~bud elongation involved in lung branching	4	7	57.1428571428571	0.0269698886607714	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	YAP1; SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.0269698886607714	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SPINK1; ANXA8; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.0269698886607714	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CTSV; HNF4A; NR0B2;	GO:0009749~response to glucose	3	67	4.47761194029851	0.0279137750330444	0.0946592129144771	1	1	0.943472381394518	0.983724267346631	0.757770828998506
up	HLA-G; PSMB8; IFI35;	GO:0060337~type I interferon signaling pathway	3	67	4.47761194029851	0.0279137750330444	0.0946592129144771	1	1	0.943472381394518	0.983724267346631	0.757770828998506
up	ADRA2A; KCNA5; HNF4A;	GO:0050796~regulation of insulin secretion	3	68	4.41176470588235	0.0289488588682351	0.0977750614786574	1	1	0.94433954350977	0.983724267346631	0.782713981142037
down	CASQ2; OXT; DRD2; CAV3; IRX5; SNTA1; GPD1L; BVES; EPAS1;	GO:0002027~regulation of heart rate	9	31	29.0322580645161	0.0298035011906521	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	EGFR; NTRK1; KDR; PTK2; DDR1; PTK6; TNK1; FRK; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	9	31	29.0322580645161	0.0298035011906521	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TP73; MT-ND5; CYP2E1; CCND1; FLT3; MGST2;	GO:0010243~response to organonitrogen compound	6	16	37.5	0.0299400465324519	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SPRY1; NGFR; GPC1; WNT5A; WNT4; SULF1;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	6	16	37.5	0.0299400465324519	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	EDN3; EDN2; EDNRB; EDNRA; BDKRB2; SLC6A4;	GO:0042310~vasoconstriction	6	16	37.5	0.0299400465324519	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	AREG; VEGFA; PRLR; HOXA5; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	6	16	37.5	0.0299400465324519	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	XCL1; ID2; NR0B2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	3	69	4.34782608695652	0.0300040465946101	0.100732148447374	1	1	0.945262651567942	0.983724267346631	0.806386206747053
up	RNASE2; ERN2; NUDT16;	GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic	3	69	4.34782608695652	0.0300040465946101	0.100732148447374	1	1	0.945262651567942	0.983724267346631	0.806386206747053
down	ANXA9; APOE; RAPSN; CHRNB3; CHRNB4; CHRNG; CHRND; CHRNA2;	GO:0007271~synaptic transmission, cholinergic	8	26	30.7692307692308	0.0308065712317915	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	FMO1; FMO2; CYP2J2; CYP2A7; CYP2E1; CYP2A6; CYP2G1P;	GO:0006082~organic acid metabolic process	7	21	33.3333333333333	0.0310477740680345	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	PSMB8; ALOXE3; RETN;	GO:0045444~fat cell differentiation	3	70	4.28571428571429	0.031079295644352	0.103927187423062	1	1	0.946247300163325	0.983724267346631	0.831963298070188
down	CHL1; PDZD2; EFS; EDIL3; NRP2; VWF; ATP1B1; PTPRF; CCL2; CEACAM1; ITGB4; ITGA2; ITGB6; VCAM1; KITLG; CD9; CDH3; LAMA1; EPHA2; EPHA3; L1CAM; MCAM; EFNB2; EMP2; MFAP4; BCAR1; IL2; RND3; CX3CL1; SRPX; EFNB1; DST; TYRO3; DDR1; TROAP; CNTN1; SLAMF1; LSAMP; SEMA5A; TPBG; LAMC2; COL4A6; DSG2; MYBPC2; HES1; DSC3; COL19A1; POSTN; GRHL2; PPFIBP1; EGFL6; SPACA4; PTPRU; CNTNAP3B; MAGI1; OMD; FERMT1; BOC; NTM; CLCA2; ROBO1; PCDH17; PCDH1; PCDHB13; SIGLEC6; PCDH7; PCDHB14; PCDHGC3; PCDHGA9; PCDH18; PARD3; PCDHGB7; PCDHGB5;	GO:0007155~cell adhesion	73	454	16.079295154185	0.0324879769253351	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	PTPN2; HHEX; CD79B;	GO:0030183~B cell differentiation	3	72	4.16666666666667	0.0332897832379309	0.107301711344159	1	1	0.948427593481674	0.983724267346631	0.858977211565067
down	ADAMTS9; FBXO2; FBXO27; FBXO17; NCCRP1;	GO:0006516~glycoprotein catabolic process	5	12	41.6666666666667	0.0341097838633184	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	VEGFA; MYH11; CXADR; SGCD; MYOM3;	GO:0048739~cardiac muscle fiber development	5	12	41.6666666666667	0.0341097838633184	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	CEACAM1; ALOX12; CD9; ADAMTS18; C1QTNF1;	GO:0090331~negative regulation of platelet aggregation	5	12	41.6666666666667	0.0341097838633184	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	CNN1; TJP1; CNN3; MYH14; LIMCH1; FRMD5; EPB41L1; FRMD6; EPB41L4A;	GO:0031032~actomyosin structure organization	9	32	28.125	0.0345201438032519	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	WWC1; REEP6; REEP1;	GO:0032386~regulation of intracellular transport	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	OSM; LIFR; OSMR;	GO:0038165~oncostatin-M-mediated signaling pathway	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	MSX1; PAX9; SP6;	GO:0042481~regulation of odontogenesis	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	HOXA5; JAG1; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PLD2; PLD1; TNFAIP8L3;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SOX9; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	DRD2; DRD3; RGS4;	GO:0060160~negative regulation of dopamine receptor signaling pathway	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	ETV5; WNT5A; CAV3;	GO:0060762~regulation of branching involved in mammary gland duct morphogenesis	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	AKR1C4; AKR1C2; AKR1C1;	GO:0071395~cellular response to jasmonic acid stimulus	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	BMP4; SOX9; SOX8;	GO:0090184~positive regulation of kidney development	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	NUPR1; MDK; YAP1;	GO:1904036~negative regulation of epithelial cell apoptotic process	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TJP1; OCLN; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0345538890504655	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	OXT; CRYAB; TFPI; HPGD; AREG; GJA1; IGFBP2; BMP7; PTN; CCND1; NR2F2; GJB2; SLC6A1; SLC6A4; FOXA1; STXBP1; POSTN; WNT8B; ARNT2; WFDC1; ANXA1;	GO:0032355~response to estradiol	21	103	20.3883495145631	0.0345759584740153	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CLCA1; CACNG6; NMUR1;	GO:0006816~calcium ion transport	3	74	4.05405405405405	0.0355798860946412	0.107301711344159	1	1	0.950943316541307	0.983724267346631	0.858977211565067
down	NFASC; ERBB2; ERBB3; EDNRB; ALDH3A2; SOX8; PMP22; BDNF;	GO:0007422~peripheral nervous system development	8	27	29.6296296296296	0.0361462778625258	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	RHOD; THY1; ITGA2; CTTN; TRIP6; AJUBA; DLC1; SORBS1;	GO:0048041~focal adhesion assembly	8	27	29.6296296296296	0.0361462778625258	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SRPX2; ITGB4; EPHA2; DST; PTK2; CTTN; PLD1; PLD2;	GO:0048870~cell motility	8	27	29.6296296296296	0.0361462778625258	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	HLA-G; PSMB8; PSME1;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	3	75	4	0.0367546374098279	0.107301711344159	1	1	0.952352121454701	0.983724267346631	0.858977211565067
down	PIR; BMP4; MT1G; VEGFA; PPARG; IL31RA;	GO:0030224~monocyte differentiation	6	17	35.2941176470588	0.0367860000596357	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	GPR31; IL10; CD24; TLR9;	GO:0002237~response to molecule of bacterial origin	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	CEACAM1; PTN; EMP2; PTK2;	GO:0010594~regulation of endothelial cell migration	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PDLIM1; NCKAP1L; DST; DLG5;	GO:0030011~maintenance of cell polarity	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PLPP3; PTPRU; TJP2; XG;	GO:0034109~homotypic cell-cell adhesion	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	DBH; MAOA; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	IGFBP2; IGFBP4; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TOM1L1; BMP4; BMP7; TOM1L2;	GO:0045839~negative regulation of mitotic nuclear division	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	BDNF; CRABP2; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	BMP7; FGFR2; HMGA2; WWTR1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.0369482973883288	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	DLG5; VANGL2; DLG2; DLG3; PARD3; LRRC1; CRB1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	7	22	31.8181818181818	0.037099605660077	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	BIRC5; ATP8B1; SNAI2; GJB6; TFAP2A; GABRB3; GJB2; SLC1A3; ALDH7A1; TMPRSS3; ROR1; GRAP; CRYM; USH1G; OTOA; MYH14; NAV2; LOXHD1; MARVELD2; ADGRV1; EYA1; SLITRK6; EPS8L2; SLC52A3; HOMER2; FZD4; MYO6;	GO:0007605~sensory perception of sound	27	143	18.8811188811189	0.0386822260188245	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	LAMA5; SPINT1; VWF; DCN; CDH1; ITGB4; ITGA2; ITGB5; ITGB6; VCAM1; FBLN1; LAMA1; ITGA3; LOX; KDR; SOX9; LAMB2; ELF3; PTK2; DDR1; LAMB3; LAMC2; COL4A6; COL19A1; VWA1; NPNT; ADAMTSL2; EGFL6; APBB2; ERO1A; SMOC2; SPINK5; ADAMTS9; LAMC3; COL17A1; COL22A1; MMP28; GFOD2; MMP19; POSTN;	GO:0030198~extracellular matrix organization	40	230	17.3913043478261	0.0396204240446022	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	BMP4; SDC1; FGFR2; PAX9; OSR1; AQP3; PITX2; WNT10A; TUFT1;	GO:0042476~odontogenesis	9	33	27.2727272727273	0.0397255159768372	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	LAMA5; BIRC5; IL2RA; ANXA1; CSF3; GHR; CCL2; OSM; VEGFA; MUC1; IL1RN; SDC1; VCAM1; EDN2; MAOA; IL10; CCND1; CD80; IL13; OPRM1; FLT3; LIFR; SOX2; RORC; CCR5; IL2; CX3CL1; CCL20; IL18; IRF4; CTF1; IL31; IL20RB; IL34; IL22RA1; IL17RD; IL31RA; NDN; OSMR; IL22; IL1RL2; IL26; DUOX1; IL20; IL36A; FZD4; IFNA5;	GO:0019221~cytokine-mediated signaling pathway	47	278	16.9064748201439	0.0399919648688501	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CCR2; XCL1; DUOXA2;	GO:0050727~regulation of inflammatory response	3	78	3.84615384615385	0.0403968405623085	0.113283172103326	1	1	0.955537245606724	0.983724267346631	0.906860310721951
down	SNAI2; BMP4; EFNA1; SOX9; JAG1; HEYL; DLL4; ROBO1;	GO:0003180~aortic valve morphogenesis	8	28	28.5714285714286	0.0420751754149532	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CTSV; TSPAN8; KRT9; WFDC2; SLC22A16; ODF3; PROK2; PRSS21;	GO:0007283~spermatogenesis	8	407	1.96560196560197	0.042557921257056	0.113283172103326	1	1	0.957346975238555	0.983724267346631	0.906860310721951
down	NRP2; VEGFA; KDR; FLT3; VEGFD;	GO:0038084~vascular endothelial growth factor signaling pathway	5	13	38.4615384615385	0.0430038135216538	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	GHRH; WNT1; CDH3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	5	13	38.4615384615385	0.0430038135216538	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	MAL; SHROOM2; DLG5; SHROOM3; VANGL2;	GO:0045176~apical protein localization	5	13	38.4615384615385	0.0430038135216538	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	IRF6; PRLR; HOXA5; SMO; ELF5;	GO:0060644~mammary gland epithelial cell differentiation	5	13	38.4615384615385	0.0430038135216538	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	HES1; PARD3; FERMT1; FRMD4A; FRMD4B;	GO:0090162~establishment of epithelial cell polarity	5	13	38.4615384615385	0.0430038135216538	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	FXYD1; CRYAB; CHRNG; GJA1; ITGB5; GLRA1; LMOD1; MYH11; CAV3; ACTA2; ACTG2; SCN7A; CHRND; SNTA1; SORBS1; MYOT; MYOM3; TNNI1; LMOD2; NOS1; LMOD3;	GO:0006936~muscle contraction	21	106	19.811320754717	0.0433168491859748	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	GLI3; DRD2; VEGFA; PAX6; CX3CL1; SMO; DCT;	GO:0002052~positive regulation of neuroblast proliferation	7	23	30.4347826086957	0.0438775994944687	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	TP73; PTN; MDK; PPARG; ASPA; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	7	23	30.4347826086957	0.0438775994944687	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	DLL1; SOX2; PRRX1; JAG1; HES1; FUT10; PROX1;	GO:0097150~neuronal stem cell population maintenance	7	23	30.4347826086957	0.0438775994944687	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	XCL2; XCL1; CCL23;	GO:0071347~cellular response to interleukin-1	3	81	3.7037037037037	0.0442142902445994	0.113283172103326	1	1	0.959329060073417	0.983724267346631	0.906860310721951
down	HPGDS; HPGD; AKR1C2; PTGR1; AKR1C4; AKR1C1;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.0445561802255485	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
up	CXCL10; CXCR1; ADGRE3; CLEC1B; CLEC4A; TRBV27;	GO:0007166~cell surface receptor signaling pathway	6	268	2.23880597014925	0.0447411730105663	0.113283172103326	1	1	0.959329060073417	0.983724267346631	0.906860310721951
up	S100A8; EPB41L4B; SPRR3;	GO:0042060~wound healing	3	82	3.65853658536585	0.0455253091689871	0.113283172103326	1	1	0.959329060073417	0.983724267346631	0.906860310721951
down	PSMB11; SNAI2; FZD6; GREM1; CTNND1; LRP4; DKK1; APOE; GLI3; IGFBP2; MDK; IGFBP4; MCC; IGFBP6; PSMB4; WNT5A; SOX2; SOX9; SOSTDC1; SFRP1; KREMEN2; PSMA8; PTPRU; FRZB; NKD2; KREMEN1; FERMT1; WWTR1; WNT5B; DKK3; DKK4; ZNRF3;	GO:0090090~negative regulation of canonical Wnt signaling pathway	32	179	17.877094972067	0.0460911532655455	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	EGFR; ERBB2; PKHD1; CEACAM1; FGFR2; EPHA2; ARHGEF5; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	8	29	27.5862068965517	0.0486128633142322	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	ALDH3A1; ALDH9A1; ALDH7A1; ALDH3A2;	GO:0006081~cellular aldehyde metabolic process	4	9	44.4444444444444	0.0487660886081542	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	PLXNB1; GREM1; SFRP1; TNN;	GO:0033689~negative regulation of osteoblast proliferation	4	9	44.4444444444444	0.0487660886081542	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	FUT1; FUT6; FUT2; FUT10;	GO:0042355~L-fucose catabolic process	4	9	44.4444444444444	0.0487660886081542	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	LOX; MYH11; MFAP4; THSD4;	GO:0048251~elastic fiber assembly	4	9	44.4444444444444	0.0487660886081542	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
down	SPINT1; FGFR2; IL10; GCM1;	GO:0060670~branching involved in labyrinthine layer morphogenesis	4	9	44.4444444444444	0.0487660886081542	0.763402215159051	1	1	0.999999999999818	0.999999999999818	1
